BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8903972)

  • 1. Modeling of sequestration and down regulation in cells containing beta2-adrenergic receptors.
    Barak LS; Caron MG
    J Recept Signal Transduct Res; 1995; 15(1-4):677-90. PubMed ID: 8903972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration.
    Barak LS; Tiberi M; Freedman NJ; Kwatra MM; Lefkowitz RJ; Caron MG
    J Biol Chem; 1994 Jan; 269(4):2790-5. PubMed ID: 7507928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts.
    Suzuki T; Nguyen CT; Nantel F; Bonin H; Valiquette M; Frielle T; Bouvier M
    Mol Pharmacol; 1992 Mar; 41(3):542-8. PubMed ID: 1347641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological sequestration of a chimeric beta 3/beta 2 adrenergic receptor occurs without a corresponding amount of receptor internalization.
    Mostafapour S; Kobilka BK; von Zastrow M
    Recept Signal Transduct; 1996; 6(3-4):151-63. PubMed ID: 9259050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down regulation of beta adrenergic receptors in S49 lymphoma cells induced by atypical agonists.
    Reynolds EE; Molinoff PB
    J Pharmacol Exp Ther; 1986 Dec; 239(3):654-60. PubMed ID: 2879029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 15-amino acid motif of the C terminus of the beta2-adrenergic receptor is sufficient to confer insulin-stimulated counterregulation to the beta1-adrenergic receptor.
    Gavi S; Yin D; Shumay E; Wang HY; Malbon CC
    Endocrinology; 2005 Jan; 146(1):450-7. PubMed ID: 15388645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist regulation of beta-adrenergic receptors: immunoblotting and indirect immunofluorescence reveal agonist-induced lateral sequestration and loss of binding.
    Wang HY; Liao JF; Malbon CC
    Chin J Physiol; 1996; 39(2):83-93. PubMed ID: 8902307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trafficking of beta2-adrenergic receptors: insulin and beta-agonists regulate internalization by distinct cytoskeletal pathways.
    Shumay E; Gavi S; Wang HY; Malbon CC
    J Cell Sci; 2004 Feb; 117(Pt 4):593-600. PubMed ID: 14709719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Frizzled-1/(beta(2))-adrenergic receptor chimera: pharmacological properties of a unique G protein-linked receptor.
    DeCostanzo AJ; Huang XP; Wang HY; Malbon CC
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):341-8. PubMed ID: 12012019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Members of the G protein-coupled receptor kinase family that phosphorylate the beta2-adrenergic receptor facilitate sequestration.
    Ménard L; Ferguson SS; Barak LS; Bertrand L; Premont RT; Colapietro AM; Lefkowitz RJ; Caron MG
    Biochemistry; 1996 Apr; 35(13):4155-60. PubMed ID: 8672451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of Tyr326 in the beta 2-adrenoceptor disrupt multiple receptor functions.
    Gabilondo AM; Krasel C; Lohse MJ
    Eur J Pharmacol; 1996 Jun; 307(2):243-50. PubMed ID: 8832227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor.
    Liggett SB; Freedman NJ; Schwinn DA; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3665-9. PubMed ID: 8386380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution.
    Morrison KJ; Moore RH; Carsrud ND; Trial J; Millman EE; Tuvim M; Clark RB; Barber R; Dickey BF; Knoll BJ
    Mol Pharmacol; 1996 Sep; 50(3):692-9. PubMed ID: 8794912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cell-surface beta-adrenergic ([3H]CGP-12177) binding in adult rat ventricular myocytes: lack of regulation by beta-agonists at physiological concentrations.
    Horackova M; Wilkinson M
    Pflugers Arch; 1992 Aug; 421(5):440-6. PubMed ID: 1361053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs.
    Green SA; Holt BD; Liggett SB
    Mol Pharmacol; 1992 May; 41(5):889-93. PubMed ID: 1350321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 20-nucleotide (A + U)-rich element of beta2-adrenergic receptor (beta2AR) mRNA mediates binding to beta2AR-binding protein and is obligate for agonist-induced destabilization of receptor mRNA.
    Tholanikunnel BG; Malbon CC
    J Biol Chem; 1997 Apr; 272(17):11471-8. PubMed ID: 9111060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific changes in beta2-adrenoceptor trafficking kinetics and intracellular sorting during downregulation.
    Moore RH; Hall HS; Rosenfeld JL; Dai W; Knoll BJ
    Eur J Pharmacol; 1999 Mar; 369(1):113-23. PubMed ID: 10204689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anomalous behavior of CGP 12177A on beta 1-adrenergic receptors.
    Pak MD; Fishman PH
    J Recept Signal Transduct Res; 1996; 16(1-2):1-23. PubMed ID: 8771528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the human beta 2-adrenergic receptor that impair coupling to Gs interfere with receptor down-regulation but not sequestration.
    Campbell PT; Hnatowich M; O'Dowd BF; Caron MG; Lefkowitz RJ; Hausdorff WP
    Mol Pharmacol; 1991 Feb; 39(2):192-8. PubMed ID: 1847493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists.
    Kikkawa H; Kurose H; Isogaya M; Sato Y; Nagao T
    Br J Pharmacol; 1997 Jul; 121(6):1059-64. PubMed ID: 9249239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.